Reni J. Benjamin
Stock Analyst at JMP Securities
(2.47)
# 2,499
Out of 5,042 analysts
10
Total ratings
50%
Success rate
16.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Reni J. Benjamin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Reiterates: Market Outperform | $40 | $19.28 | +107.47% | 3 | Oct 20, 2025 | |
| KURA Kura Oncology | Reiterates: Market Outperform | $24 | $9.70 | +147.42% | 2 | Oct 20, 2025 | |
| INBX Inhibrx Biosciences | Reiterates: Market Perform | n/a | $57.29 | - | 1 | Aug 22, 2025 | |
| HOWL Werewolf Therapeutics | Maintains: Market Outperform | $4 → $3 | $1.77 | +69.49% | 1 | Aug 21, 2025 | |
| PRLD Prelude Therapeutics | Maintains: Market Outperform | $4 → $3 | $1.62 | +85.19% | 1 | Aug 18, 2025 | |
| BCAB BioAtla | Downgrades: Market Perform | n/a | $0.76 | - | 1 | Aug 13, 2025 | |
| BCYC Bicycle Therapeutics | Maintains: Market Outperform | $22 → $10 | $7.88 | +26.90% | 1 | Aug 12, 2025 |
Summit Therapeutics
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $40
Current: $19.28
Upside: +107.47%
Kura Oncology
Oct 20, 2025
Reiterates: Market Outperform
Price Target: $24
Current: $9.70
Upside: +147.42%
Inhibrx Biosciences
Aug 22, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $57.29
Upside: -
Werewolf Therapeutics
Aug 21, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $1.77
Upside: +69.49%
Prelude Therapeutics
Aug 18, 2025
Maintains: Market Outperform
Price Target: $4 → $3
Current: $1.62
Upside: +85.19%
BioAtla
Aug 13, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $0.76
Upside: -
Bicycle Therapeutics
Aug 12, 2025
Maintains: Market Outperform
Price Target: $22 → $10
Current: $7.88
Upside: +26.90%